U.S. Markets open in 3 hrs 31 mins
  • S&P Futures

    3,936.25
    +20.00 (+0.51%)
     
  • Dow Futures

    31,607.00
    +120.00 (+0.38%)
     
  • Nasdaq Futures

    12,223.50
    +83.00 (+0.68%)
     
  • Russell 2000 Futures

    1,771.00
    +9.30 (+0.53%)
     
  • Crude Oil

    107.33
    -0.29 (-0.27%)
     
  • Gold

    1,840.80
    +10.50 (+0.57%)
     
  • Silver

    21.51
    +0.39 (+1.82%)
     
  • EUR/USD

    1.0572
    +0.0013 (+0.1269%)
     
  • 10-Yr Bond

    3.1250
    0.0000 (0.00%)
     
  • Vix

    28.25
    -0.80 (-2.75%)
     
  • GBP/USD

    1.2280
    +0.0010 (+0.0798%)
     
  • USD/JPY

    135.2070
    +0.0370 (+0.0274%)
     
  • BTC-USD

    21,466.80
    +84.40 (+0.39%)
     
  • CMC Crypto 200

    468.41
    +14.51 (+3.20%)
     
  • FTSE 100

    7,257.00
    +48.19 (+0.67%)
     
  • Nikkei 225

    26,871.27
    +379.30 (+1.43%)
     

Co-Diagnostics, Inc. to Present at Sidoti Summer Small Cap Virtual Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SALT LAKE CITY, June 15, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Dwight Egan, CEO, Brian Brown, CFO, and Andrew Benson, Head of Investor Relations, will present and host one-on-one meetings with investors at the Sidoti Summer Small Cap Virtual Investor Conference June 15-16, 2022.

Co-Diagnostics Official Logo (PRNewsfoto/Co-Diagnostics)
Co-Diagnostics Official Logo (PRNewsfoto/Co-Diagnostics)

The presentation will begin at 3:15 p.m. EDT on Wednesday June 15, 2022, and can be accessed on the Events and Webcasts section of the Co-Diagnostics website. To register for the presentation or one-on-ones, please visit www.sidoti.com/events.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-present-at-sidoti-summer-small-cap-virtual-conference-301568436.html

SOURCE Co-Diagnostics